Conveners
Medical radioisotopes
- Luciano Canton (INFN - National Institute for Nuclear Physics)
Medical radioisotopes
- Arjan Plompen
A large fraction of the radioisotopes used for diagnostics and therapy in healthcare are currently produced in research reactors build in the heydays of the development of nuclear power. These reactors will be decommissioned in the coming decade. For various reasons significantly less new reactors for research and isotope production are coming on-line. At the same time the use of radioisotopes...
Syed M. Qaim
Institut für Neurowissenschaften und Medizin, INM-5: Nuklearchemie
Forschungszentrum Jülich GmbH, 52425 Jülich, Germany
E-mail: s.m.qaim@fz-juelich.de
Nuclear data play an important role in optimisation of production routes of medical radionuclides. In general, the production data of all the commonly used diagnostic and therapeutic radionuclides are well known, except for some...
Radiopharmaceuticals containing gamma-ray and beta(-)(alpha, Auger electron)-ray emitting radioisotopes are used to diagnose the dynamics of a medicine in the living body and kill targeted cancer cells, respectively. Using 99mTc (T1/2 = 6 h), the daughter nuclide of 99Mo (T1/2 = 66 h), about 0.9 million and 6 million diagnostic procedures per year are carried out in Japan and in EU,...
The aim of this work is the analysis of 67Cu and 47Sc production by using high-energy and high-intensity cyclotrons, as the one operating at Arronax facility (Nantes, France) and the one recently installed at Legnaro National Laboratories (INFN-LNL, Padova, Italy), in the framework of SPES project. The aim of the SPES project is focused both on the use of Radioactive Ion Beams (RIB) in nuclear...
The production of innovative radionuclides in the context of theranostics (i.e. the combined therapy and diagnostics) is currently a topic of great interest and the new generation of proton cyclotrons is offering many new routes for their production with charged particle beams, as an alternative to the more traditional neutron reactions at reactors. Many candidates have been identified by...
Cancer management is a major medical and economic issue because of the increasing incidence of the disease in the world. The need for radioisotopes in both cancer diagnosis and therapy is very well established. These needs have been addressed through a series of IAEA Coordinated Research Projects running for the last 20 years.
Experimental data compilations, theoretical calculations and...
Nuclear medicine is a specialty that uses radioactive nuclei for therapy or diagnostic of diseases such as different types of cancer. These radionuclides are most of the time coupled with carrier molecules to target cells of interest. Currently, only few radionuclides are deployed in clinical practice. However, many others may be of medical interest due to their emitted radiation, their...
Aim
Recently there has been growing interest in the medical application of $^{97}$Ru isotope. It is intended to be useful for both diagnostic and therapeutic purposes due to its convenient physical properties ($T_{1/2}$ = 2.9 d, gamma lines 215.7 keV, 85.8% and 324.5 keV, 10.2%, decay 100% EC with no $\beta$+ to contribute to the dose). Its chemical properties are also favourable, as it...
